An impaired sulfoxidation pathway has been implicated in the pathogenesis of chlorpromazineinduced hepatotoxicity. Since some patients with chronic chlorpromazine-induced cholestasis may have features of primary biliary cirrhosis, we studied the ability to sulfoxidate the amino acid analogue 5'-carb
Calcitriol for bone loss in patients with primary biliary cirrhosis
โ Scribed by Susumu Shiomi; Kyoko Masaki; Daiki Habu; Tadashi Takeda; Shuhei Nishiguchi; Tetsuo Kuroki; Hironobu Ochi
- Publisher
- Springer Japan
- Year
- 1999
- Tongue
- English
- Weight
- 81 KB
- Volume
- 34
- Category
- Article
- ISSN
- 0944-1174
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
Symptomatology and objective findings of Sjogren's syndrome were evaluated in 38 consecutive patients with primary biliary cirrhosis. Symptoms of Sjogren's syndrome were present in 18 (47.4%) patients, but were severe enough to warrant therapy in only four (10.6%). Nineteen patients consented to eva
The impact of primary biliary cirrhosis (PBC) on health-related quality of life (HRQOL) is poorly documented. We assessed quality of life in a group of 276 unselected patients with PBC using the Nottingham Health Profile (NHP). This is a generic scale that assesses six major areas commonly associate
No satisfactory treatment is available for metabolic bone disease associated with primary biliary cirrhosis. On the basis of the similarities to postmenopausal osteoporosis, the rationale exists for calcitonin to be tested in clinical studies in patients with primary biliary cirrhosis-associated ost